Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse

A substantial fraction of patients with stage I–III colorectal adenocarcinoma (CRC) experience disease relapse after surgery with curative intent. However, biomarkers for predicting the likelihood of CRC relapse have not been fully explored. Therefore, we assessed the association between tumor infil...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamal, Yasmin, Dwan, Dennis, Hoehn, Hannah J., Sanz-Pamplona, Rebeca, Alonso, M. Henar, Moreno, Victor, Cheng, Chao, Schell, Michael J., Kim, Youngchul, Felder, Seth I., Rennert, Hedy S., Melas, Marilena, Lazaris, Charalampos, Bonner, Joseph D., Siegel, Erin M., Shibata, David, Rennert, Gad, Gruber, Stephen B., Frost, H. Robert, Amos, Christopher I., Schmit, Stephanie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951964/
https://www.ncbi.nlm.nih.gov/pubmed/33763292
http://dx.doi.org/10.1080/2162402X.2020.1862529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951964/
https://www.ncbi.nlm.nih.gov/pubmed/33763292
http://dx.doi.org/10.1080/2162402X.2020.1862529

Ejemplares similares